Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study

Marinus J. Hagens, Daniela E. Oprea-Lager, André N. Vis, Maurits Wondergem, Maarten L. Donswijk, Dennie Meijer, Louise Emmett, Pim J. van Leeuwen and Henk G. van der Poel
Journal of Nuclear Medicine October 2022, 63 (10) 1531-1536; DOI: https://doi.org/10.2967/jnumed.121.263139
Marinus J. Hagens
1Department of Urology, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands;
2Department of Urology, Amsterdam University Medical Centers Location VUmc, Amsterdam, The Netherlands;
3Prostate Cancer Network Netherlands, Amsterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniela E. Oprea-Lager
4Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers Location VUmc, Amsterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
André N. Vis
2Department of Urology, Amsterdam University Medical Centers Location VUmc, Amsterdam, The Netherlands;
3Prostate Cancer Network Netherlands, Amsterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maurits Wondergem
5Department of Nuclear Medicine, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maarten L. Donswijk
5Department of Nuclear Medicine, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dennie Meijer
2Department of Urology, Amsterdam University Medical Centers Location VUmc, Amsterdam, The Netherlands;
3Prostate Cancer Network Netherlands, Amsterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Louise Emmett
6Department of Diagnostic Imaging, St. Vincent’s Public Hospital, and Australia University of New South Wales, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pim J. van Leeuwen
1Department of Urology, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands;
3Prostate Cancer Network Netherlands, Amsterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henk G. van der Poel
1Department of Urology, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands;
2Department of Urology, Amsterdam University Medical Centers Location VUmc, Amsterdam, The Netherlands;
3Prostate Cancer Network Netherlands, Amsterdam, The Netherlands;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 63 no. 10 1531-1536
DOI 
https://doi.org/10.2967/jnumed.121.263139
PubMed 
36008118

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication August 30, 2021
  • Accepted for publication February 10, 2022
  • Published online October 3, 2022.

Article Versions

  • previous version (August 25, 2022 - 12:11).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Marinus J. Hagens1,2,3,
  2. Daniela E. Oprea-Lager4,
  3. André N. Vis2,3,
  4. Maurits Wondergem5,
  5. Maarten L. Donswijk5,
  6. Dennie Meijer2,3,
  7. Louise Emmett6,
  8. Pim J. van Leeuwen1,3 and
  9. Henk G. van der Poel1,2,3
  1. 1Department of Urology, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands;
  2. 2Department of Urology, Amsterdam University Medical Centers Location VUmc, Amsterdam, The Netherlands;
  3. 3Prostate Cancer Network Netherlands, Amsterdam, The Netherlands;
  4. 4Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers Location VUmc, Amsterdam, The Netherlands;
  5. 5Department of Nuclear Medicine, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; and
  6. 6Department of Diagnostic Imaging, St. Vincent’s Public Hospital, and Australia University of New South Wales, Sydney, New South Wales, Australia
  1. For correspondence or reprints, contact Marinus J. Hagens (m.hagens{at}nki.nl).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 14 Citations
  • 17 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer
    Marinus J. Hagens, Wietske I. Luining, Auke Jager, Maarten L. Donswijk, Zing Cheung, Maurits Wondergem, Daniela E. Oprea-Lager, André N. Vis, Pim J. van Leeuwen, Henk G. van der Poel
    Journal of Nuclear Medicine 2023 64 8
  • [18F]DCFPyL PET/CT versus [18F]fluoromethylcholine PET/CT in Biochemical Recurrence of Prostate Cancer (PYTHON): a prospective, open label, cross-over, comparative study
    Daniela-Elena Oprea-Lager, Eric Gontier, Lina García-Cañamaque, Mathieu Gauthé, Pierre Olivier, Mercedes Mitjavila, Pilar Tamayo, Philippe Robin, Ana Maria García Vicente, Anne-Charlotte Bouyeure, Alban Bailliez, Antonio Rodríguez-Fernández, Sinan Ben Mahmoud, Juan Antonio Vallejo-Casas, Philippe Maksud, Charles Merlin, Paul Blanc-Durand, Clément Drouet, Hubert Tissot, Irina Vierasu, Thierry Vander Borght, Evelyne Boos, Florence Chossat, Marina Hodolic, Caroline Rousseau
    European Journal of Nuclear Medicine and Molecular Imaging 2023 50 11
  • Standardized template for clinical reporting of PSMA PET/CT scans
    Shadi A. Esfahani, Michael J. Morris, Oliver Sartor, Mark Frydenberg, Stefano Fanti, Jeremie Calais, Neha Vapiwala
    European Journal of Nuclear Medicine and Molecular Imaging 2024 52 1
  • 18F-PSMA-11 as an Attractive 68Ga-PSMA-11 Alternative for Prostate Cancer Imaging
    Pim J. van Leeuwen, Louise Emmett
    European Urology 2022 82 5
  • The Future of Radioligand Therapies in Metastatic Castrate-Resistant Prostate Cancer
    Charles B. Nguyen, Ajjai S. Alva
    Advances in Oncology 2023 3 1
  • The Probability of Metastases Within Different Prostate-specific Antigen Ranges Using Prostate-specific Membrane Antigen Positron Emission Tomography in Patients with Newly Diagnosed Prostate Cancer
    Wietske I. Luining, Marinus J. Hagens, Dennie Meijer, Joanneke B. Ringia, Tessa de Weijer, Huseyyin O. Bektas, Rosemarijn H. Ettema, Remco J.J. Knol, Ton A. Roeleveld, Sandra Srbljin, Saskia Weltings, Jose C.C. Koppes, Reindert J.A. van Moorselaar, Pim J. van Leeuwen, Daniela E. Oprea-Lager, André N. Vis
    European Urology Open Science 2024 59
  • A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment
    Elio Mazzone, Donato Cannoletta, Leonardo Quarta, David C. Chen, Alice Thomson, Francesco Barletta, Armando Stabile, Daniel Moon, Renu Eapen, Nathan Lawrentschuk, Francesco Montorsi, Shankar Siva, Michael S. Hofman, Arturo Chiti, Declan G. Murphy, Alberto Briganti, Marlon L. Perera
    European Urology 2025 87 6
  • Imaging and therapy in prostate cancer using prostate specific membrane antigen radioligands
    Mitesh Naik, Sairah R Khan, Valerie Lewington, Amarnath Challapalli, Amy Eccles, Tara D Barwick
    British Journal of Radiology 2024 97 1160
  • Not All Prostate-Specific Membrane Antigen Imaging Agents Are Created Equal: Diagnostic Accuracy of Ga-68 PSMA-11 PET/CT for Initial and Recurrent Prostate Cancer
    Andrei S. Purysko, Andre L. Abreu, Daniel W. Lin, Sanoj Punnen
    Applied Radiology 2024
  • Role of 18F-PSMA-1007 PET/CT-derived quantitative volumetric tumor parameters in cytoreductive radical prostatectomy selection for patients with low-volume metastatic hormone-sensitive prostate cancer: a retrospective study
    Junjie Fan, Ke Xu, Zhangdong Jiang, Chaosheng Gan, Hao Song, Guoqiang Gao, Guojing Wang, Qiyuan Kang, Liang Luo, Zhuonan Wang, Dalin He, XiaoYi Duan, Kaijie Wu
    BMC Cancer 2025 25 1

Article usage

Article usage: August 2022 to April 2025

AbstractFullPdf
Aug 20221002045
Sep 20221739072
Oct 202213745155
Nov 20223901914
Dec 20225552012
Jan 202352645
Feb 20235101018
Mar 20235251514
Apr 20235622116
May 20232915723
Jun 20231721528
Jul 20232022316
Aug 20233431123
Sep 20232526027
Oct 20231712522
Nov 20231911725
Dec 2023146621
Jan 20243415119
Feb 20242420130
Mar 20241614760
Apr 2024327236
May 2024135021
Jun 2024326423
Jul 2024924132
Aug 2024834427
Sep 2024114125
Oct 2024195116
Nov 202475831
Dec 202482820
Jan 2025102619
Feb 2025108412
Mar 202575421
Apr 2025148329
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 63 (10)
Journal of Nuclear Medicine
Vol. 63, Issue 10
October 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study
Marinus J. Hagens, Daniela E. Oprea-Lager, André N. Vis, Maurits Wondergem, Maarten L. Donswijk, Dennie Meijer, Louise Emmett, Pim J. van Leeuwen, Henk G. van der Poel
Journal of Nuclear Medicine Oct 2022, 63 (10) 1531-1536; DOI: 10.2967/jnumed.121.263139

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study
Marinus J. Hagens, Daniela E. Oprea-Lager, André N. Vis, Maurits Wondergem, Maarten L. Donswijk, Dennie Meijer, Louise Emmett, Pim J. van Leeuwen, Henk G. van der Poel
Journal of Nuclear Medicine Oct 2022, 63 (10) 1531-1536; DOI: 10.2967/jnumed.121.263139
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENT
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Diagnostic Value of PSMA PET/CT in Men with Newly Diagnosed Unfavorable Intermediate-Risk Prostate Cancer
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

Keywords

  • PSMA PET
  • prostate cancer
  • staging
  • radiotracers
  • interobserver variability
SNMMI

© 2025 SNMMI

Powered by HighWire